Sativex multiple sclerosis drug

Sativex multiple sclerosis drug

C011/0050 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.3MB

Downloadable file size: 554.2KB

Price image Pricing

Please login to use the price calculator


Caption: Sativex multiple sclerosis drug. Sativex is a cannabinoid oromucosal mouth spray developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. It is also being trialled as a pain control drug for cancer patients.

Release details: Model release not required. Property release not available.

Keywords: analgesic, bottle, device, drug, gw pharmaceuticals, medical, medicine, mouth spray, ms, multiple sclerosis, nabiximols, oromucosal, pain relief, pharmacological, pharmacology, prescribed, prescription, sativex, spray, still life, still-life, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.